A low-carbohydrate as compared with a low-fat diet in severe obesity.

@article{Samaha2003ALA,
  title={A low-carbohydrate as compared with a low-fat diet in severe obesity.},
  author={Frederick F. Samaha and Nayyar Iqbal and Prakash Seshadri and Kathryn L. Chicano and Denise A. Daily and Joyce McGrory and Terrence Williams and Monica M Williams and Edward J Gracely and Linda Stern},
  journal={The New England journal of medicine},
  year={2003},
  volume={348 21},
  pages={
          2074-81
        }
}
BACKGROUND The effects of a carbohydrate-restricted diet on weight loss and risk factors for atherosclerosis have been incompletely assessed. METHODS We randomly assigned 132 severely obese subjects (including 77 blacks and 23 women) with a mean body-mass index of 43 and a high prevalence of diabetes (39 percent) or the metabolic syndrome (43 percent) to a carbohydrate-restricted (low-carbohydrate) diet or a calorie- and fat-restricted (low-fat) diet. RESULTS Seventy-nine subjects completed… 

Figures and Tables from this paper

Effects of low-carbohydrate and low-fat diets: a randomized trial.

The low-carbohydrate diet was more effective for weight loss and cardiovascular risk factor reduction than the low-fat diet and Restricting carbohydrate may be an option for persons seeking to lose weight and reduce cardiovascular risk factors.

Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet

Successful weight loss can be achieved with either a low-fat or low-carbohydrate diet when coupled with behavioral treatment, and aLow- carbohydrate diet is associated with favorable changes in cardiovascular disease risk factors at 2 years.

Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia.

Moderate carbohydrate restriction and weight loss provide equivalent but nonadditive approaches to improving atherogenic dyslipidemia.

The Effects of Low-Carbohydrate versus Conventional Weight Loss Diets in Severely Obese Adults: One-Year Follow-up of a Randomized Trial

The findings 1 year after randomization to a low-carbohydrate diet versus a high-fat weight loss diet (conventional diet) in severely obese adults with a high prevalence of diabetes or the metabolic syndrome are reported.

A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipidemia

Body weight, body composition, serum lipid levels, and adverse effects over 24 weeks in hyperlipidemic persons who were randomly assigned to follow a low-carbohydrate, ketogenic, or low-fat, low-cholesterol, reduced-calorie diet are examined.

Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipemia differently in overweight men.

The very low-carbohydrate diet was more effective at improving characteristics of the metabolic syndrome as shown by a decrease in fasting serum TAG, the TAG/HDL-C ratio, postprandial lipemia, serum glucose, an increase in LDL particle size, and also greater weight loss.
...

References

SHOWING 1-10 OF 21 REFERENCES

Dietary Protein and Weight Reduction

High-protein diets have recently been proposed as a “new” strategy for successful weight loss, but there are no long-term scientific studies to support their overall efficacy and safety and individuals who follow these diets are at risk for compromised vitamin and mineral intake.

A Review of Very Low Carbohydrate Diets for Weight Loss

There is some evidence that very low carbohydrate diets can lead to significant metabolic changes including weight loss, but the long-term risks and benefits are not established, and further research is in order.

Dietary protein and weight reduction: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association.

High-protein diets are not recommended because they restrict healthful foods that provide essential nutrients and do not provide the variety of foods needed to adequately meet nutritional needs, and individuals who follow these diets are therefore at risk for compromised vitamin and mineral intake.

Coronary Heart Disease in Patients With Low LDL-Cholesterol: Benefit of Pravastatin in Diabetics and Enhanced Role for HDL-Cholesterol and Triglycerides as Risk Factors

Pravastatin reduced the event rate in diabetics to that of nondiabetic participants, and the results suggest enhanced therapeutic potential for improving HDL-C and triglycerides in patients with CHD who have low LDL-C concentrations.

GEMFIBROZIL FOR THE SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MEN WITH LOW LEVELS OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL

Gemfibrozil therapy resulted in a significant reduction in the risk of major cardiovascular events in patients with coronary disease whose primary lipid abnormality was a low HDL cholesterol level, suggesting that the rate of coronary events is reduced by raising HDL cholesterol levels and lowering levels of triglycerides without lowering LDL cholesterol levels.

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Gemfibrozil therapy resulted in a significant reduction in the risk of major cardiovascular events in patients with coronary disease whose primary lipid abnormality was a low HDL cholesterol level, suggesting that the rate of coronary events is reduced by raising HDL cholesterol levels and lowering levels of triglycerides without lowering LDL cholesterol levels.

Validity of the 24-hour dietary recall.